Search Results - "Gangula, Srinivas"
-
1
Commercial-Scale Visible Light Trifluoromethylation of 2‑Chlorothiophenol Using CF3I Gas
Published in Organic process research & development (18-02-2022)“…Despite the growth of photoredox methods in academia, application of photoredox at scale in the pharmaceutical and fine chemical industries has been slow. In…”
Get full text
Journal Article -
2
Investigation of a Kumada Cross Coupling Reaction for Large-Scale Production of (2S, 7R, E)‑2-Isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)‑N,N,8-trimethylnon-4-enamide
Published in Organic process research & development (20-03-2015)“…An investigation into the Kumada cross coupling reaction was conducted by developing a reliable, efficient procedure for the Grignard reagent and its…”
Get full text
Journal Article -
3
An Improved Process for Repaglinide via an Efficient and One Pot Process of (1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine – A Useful Intermediate
Published in Chimia (01-09-2006)“…The development of a large-scale synthesis for (1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine (S-(+)-1), a key intermediate of repaglinide (2), is…”
Get full text
Journal Article -
4
Commercial-Scale Visible Light Trifluoromethylation of 2-Chlorothiophenol Using CF 3 I Gas
Published in Organic process research & development (18-02-2022)Get full text
Journal Article -
5
Synthesis, Optimization, and Large-Scale Preparation of the Low-Dose Central Nervous System-Penetrant BACE1 Inhibitor LY3202626 via a [3 + 2] Nitrone Cycloaddition
Published in Organic process research & development (21-02-2020)“…Herein we report a summary of the synthetic development of LY3202626 from the initial discovery route to a final route that was scaled to make 150 kg. Key…”
Get full text
Journal Article -
6
Application of Continuous Flow Micromixing Reactor Technology for Synthesis of Benzimidazole Drugs
Published in Organic process research & development (18-10-2013)“…Synthesis of pharmaceutically active compounds by employing continuous flow micromixing reactor technology is an interesting research area. In this article we…”
Get full text
Journal Article -
7
Improved Process for Paroxetine Hydrochloride Substantially Free from Potential Impurities
Published in Synthetic communications (15-11-2012)“…An efficient process for production of paroxetine hydrochloride hemihydrate 1, a selective 5-hydroxytryptamine (serotonin) reuptake inhibitor, is described…”
Get full text
Journal Article -
8
An efficient synthesis of dexlansoprazole employing asymmetric oxidation strategy
Published in Tetrahedron letters (19-10-2011)“…An alternative and scalable synthesis of dexlansoprazole (( R)-(+)- 1); the ( R)-enantiomer of Lansoprazole with an enantiomeric excess of >99.8% is presented…”
Get full text
Journal Article -
9
An Improved Process for the Production of Lansoprazole: Investigation of Key Parameters That Influence the Water Content in Final API
Published in Organic process research & development (15-01-2010)“…An improved large-scale synthesis of lansoprazole 1 an anti-ulcer drug is described. The synthesis commences with condensation of 2-mercaptobenzimadazole 3…”
Get full text
Journal Article -
10
Synthesis of All Enantiomerically Pure Diastereomers of Aprepitant
Published in Synthetic communications (12-07-2010)“…Syntheses of all eight enantiomerically pure diastereomers of aprepitant and assignment of absolute configuration at newly generated stereocenters by NMR and…”
Get full text
Journal Article -
11
Novel Synthesis of Fosphenytoin: Anti-Convulsant Prodrug
Published in Synthetic communications (18-08-2008)“…A simple, new synthesis of fosphenytoin sodium 1, a prodrug, via imidate ester and employing mild reaction conditions is described…”
Get full text
Journal Article -
12
A convergent approach to the synthesis of aprepitant: a potent human NK-1 receptor antagonist
Published in Tetrahedron letters (05-11-2007)“…A convergent approach to enantiomerically pure aprepitant a potent orally active antagonist of the human neurokinin-1 (NK-1) receptor, is described. A simple…”
Get full text
Journal Article -
13
An Alternative Approach to Achieve Enantiopure (3S)-4-Benzyl-3- (4-fluorophenyl)morpholin-2-one: A Key Intermediate of Aprepitant, an NK1 Receptor Antagonist
Published in Organic process research & development (01-05-2007)“…An efficient and alternative synthesis of enantiomerically pure (3S)-4-benzyl-3-(4-fluorophenyl)morpholin-2-one (S)-(+)-2), a key intermediate in the synthesis…”
Get full text
Journal Article -
14
Substrate Modification Approach to Achieve Efficient Resolution: Didesmethylcitalopram: A Key Intermediate for Escitalopram
Published in Organic process research & development (01-03-2007)“…Research work presented here describes an approach to achieve the enantiopure escitalopram (1) via didesmethyl escitalopram (4), which is easily resolvable…”
Get full text
Journal Article -
15
Substrate Modification Approach to Achieve Efficient Resolution: Didesmethylcitalopram: A Key Intermediate for Escitalopram
Published in Organic process research & development (01-07-2007)Get full text
Journal Article